Market Overview

Tickers

Articles

Keywords

Search by keyword...
googlecse

Sanofi's Genzyme Announces European Approval of Framingham Manufacturing Plant

Eddie Staley, Benzinga Staff Writer
January 18, 2012 8:04 AM
+ Follow
Print
Email
Tickers: SNY
Benzinga Share:

Genzyme, a Sanofi company (NYSE: SNY), announced today that the European Medicines Agency has approved its manufacturing plant in Framingham, Mass., for the production of Fabrazyme® (agalsidase beta).

(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Posted in: News, FDA

 

Around the Web, We're Loving...

Boston Bomb Probe Focuses on Bags and Pressure Cooker
Bank of America Falls On Q1 Results, Mortgage Settlement
What You Should Know About GOOG

Most Popular

Google Drive Goes Down, Halting Productivity for Many Users
Wii U Sales Plummet in March
Apple Broke Down - What do the Charts Say Now?
Forget The Housing Crash, This Market Has Been Booming
Allergan Receives Complete Response Letter from the FDA for LEVADEX
Coca-Cola Returning to a Franchise Model – With Conditions

Related Articles (SNY)

ETF Showdown: A Pharma Fight
Pieris and Sanofi Expand Collaboration
Sanofi and Transgene Announce Long-Term Collaboration
Moves in Smaller Health Care Stocks (ANAC, HALO, PBYI, QCOR)
3 International Dividend ETFs Your Broker Forgot to Mention
3 ADR ETFs Your Broker Forgot to Mention

Partner Network

Get Benzinga's News Delivered Free

Posts by Eddie Staley

Benzinga Professional

Subscribe